Status:
UNKNOWN
Tetrandrine Tablets Used in the Treatment of COVID-19
Lead Sponsor:
Henan Provincial People's Hospital
Conditions:
Corona Virus Disease 2019,COVID-19
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The study is expected to treat patients with mild and severe neo-coronary pneumonia through standard treatment regimens in combination with tetrandrine tablets, thereby reducing the clinical progress ...
Detailed Description
Since December 2019, a number of cases of pneumonia infected with the new coronavirus have been found in wuhan, hubei province.Has now become a global epidemic of crisis. After recent frontline anti-...
Eligibility Criteria
Inclusion
- Patients with mild and severe cases who have been diagnosed with new coronavirus pneumonia according to the "Pneumonitis Diagnosis and Treatment -
- Plan for New Coronavirus Infection"
- Age 18 to 75 years;
- Sign the informed consent voluntarily.
Exclusion
- With active tuberculosis, idiopathic pulmonary fibrosis, bronchial asthma, bronchiectasis, pulmonary embolism, patients with chronic respiratory failure or other severe respiratory disease;
- According to the "pneumonia diagnosis and treatment program for new coronavirus infection" (trial version 6), critically ill patients
- With severe patients with disease of heart head blood-vessel, malignant arrhythmia, unstable angina, acute myocardial infarction and death, cardiac function level 3 and above, stroke, cerebral hemorrhage, etc.);
- With severe liver and kidney diseases (severe liver disease refers to cirrhosis, portal hypertension and varices bleeding, severe kidney disease including dialysis, kidney transplantation);
- Pregnant and lactating women;
- Severe cognitive and mental disorders;
- Clinical investigators who were participating in other interventions within 1 month prior to inclusion
Key Trial Info
Start Date :
March 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04308317
Start Date
March 5 2020
End Date
May 1 2021
Last Update
March 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tetrandrine Tablets
Jinhua, Zhejiang, China, 321000